Literature DB >> 28799027

Optimal Lymphadenectomy for Duodenal Adenocarcinoma: Does the Number Alone Matter?

Taro Sakamoto1,2, Akio Saiura3, Yoshihiro Ono1, Yoshihiro Mise1, Yosuke Inoue1, Takeaki Ishizawa1, Yu Takahashi1, Hiromichi Ito1.   

Abstract

BACKGROUND: Duodenal adenocarcinoma (DA) is a rare disease, and the optimal extent of lymphadenectomy and the role of limited resection remain controversial.
OBJECTIVE: The aim of our study was to assess the pattern of regional lymph node spread of DA and to determine the optimal extent of resection.
METHODS: A total of 65 patients who underwent curative resection for DA at our institution from 1989 through 2015 were included in this study. Clinicopathologic factors associated with long-term outcomes and the patterns of regional node spread per primary tumor location were evaluated.
RESULTS: Fifty-one patients (78%) underwent pancreaticoduodenectomy (PD), with the remainder undergoing limited resection. The median number of retrieved lymph nodes was 24 (range 1-63) and 48% of patients had regional node metastasis. The 5-year overall survival (OS) rate was 67%. In the multivariate analysis, regional node and para-aortic lymph node metastasis were risk factors associated with poorer OS (hazard ratio [HR] 12.1 [p = 0.025], and HR 3.2 [p = 0.045], respectively). While pancreaticoduodenal (#13) and superior mesenteric (#14) lymph node stations were commonly involved by both distal and proximal DA (33 vs. 39% for #13, p = 0.39; and 33 vs. 22% for #14, p = 0.27), the pyloric lymph node station was much less involved by distal DA than proximal DA (0 vs. 37%, p = 0.036).
CONCLUSION: The pancreaticoduodenal lymph node station was the most commonly involved lymph node in DA, and PD should be the standard operation for DA. Segmental resection should only be reserved for patients with distal DA who are physically unfit for PD.

Entities:  

Mesh:

Year:  2017        PMID: 28799027     DOI: 10.1245/s10434-017-6044-7

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  9 in total

Review 1.  Limited resection vs. pancreaticoduodenectomy for primary duodenal adenocarcinoma: a systematic review and meta-analysis.

Authors:  Pipit Burasakarn; Ryota Higuchi; Souya Nunobe; Shingo Kanaji; Hidetoshi Eguchi; Ken-Ichi Okada; Tsutomu Fujii; Yuichi Nagakawa; Kengo Kanetaka; Hiroharu Yamashita; Suguru Yamada; Shinji Kuroda; Toru Aoyama; Takahiro Akahori; Kenji Nakagawa; Masakazu Yamamoto; Hiroki Yamaue; Masayuki Sho; Yasuhiro Kodera
Journal:  Int J Clin Oncol       Date:  2021-01-01       Impact factor: 3.402

2.  Segmental resection with partial mesopancreatic and mesojejunal excision (pMME) for duodenal carcinoma of the third or fourth portion.

Authors:  Ryota Ito; Yoshihiro Mise; Yu Takahashi; Yosuke Inoue; Fumihiro Kawano; Haruka Tanaka; Shoichi Irie; Hirofumi Ichida; Ryuji Yoshioka; Akio Saiura
Journal:  Langenbecks Arch Surg       Date:  2022-05-30       Impact factor: 2.895

Review 3.  Clinical practice guidelines for duodenal cancer 2021.

Authors:  Kenji Nakagawa; Masayuki Sho; Mitsuhiro Fujishiro; Naomi Kakushima; Takahiro Horimatsu; Ken-Ichi Okada; Mikitaka Iguchi; Toshio Uraoka; Motohiko Kato; Yorimasa Yamamoto; Toru Aoyama; Takahiro Akahori; Hidetoshi Eguchi; Shingo Kanaji; Kengo Kanetaka; Shinji Kuroda; Yuichi Nagakawa; Souya Nunobe; Ryota Higuchi; Tsutomu Fujii; Hiroharu Yamashita; Suguru Yamada; Yukiya Narita; Yoshitaka Honma; Kei Muro; Tetsuo Ushiku; Yasuo Ejima; Hiroki Yamaue; Yasuhiro Kodera
Journal:  J Gastroenterol       Date:  2022-10-19       Impact factor: 6.772

4.  Outcomes and Treatment Options for Duodenal Adenocarcinoma: A Systematic Review and Meta-Analysis.

Authors:  Laura L Meijer; Anna J Alberga; Jacob K de Bakker; Hans J van der Vliet; Tessa Y S Le Large; Nicole C T van Grieken; Ralph de Vries; Freek Daams; Barbara M Zonderhuis; Geert Kazemier
Journal:  Ann Surg Oncol       Date:  2018-06-26       Impact factor: 5.344

5.  ASO Author Reflections: Current Treatment Options for Duodenal Adenocarcinoma-A Call for Collaborative Studies.

Authors:  Laura L Meijer; Geert Kazemier
Journal:  Ann Surg Oncol       Date:  2018-10-16       Impact factor: 5.344

Review 6.  Endoscopic resection of superficial non-ampullary duodenal epithelial tumor.

Authors:  Motohiko Kato; Takanori Kanai; Naohisa Yahagi
Journal:  DEN open       Date:  2021-09-05

7.  Pancreas-preserving partial duodenectomy for non-ampullary duodenal neoplasms: three case reports.

Authors:  Shunsuke Ishida; Teijiro Hirashita; Yoko Kawano; Hiroki Orimoto; Shota Amano; Masahiro Kawamura; Atsuro Fujinaga; Takahide Kawasaki; Takashi Masuda; Yuichi Endo; Masayuki Ohta; Masafumi Inomata
Journal:  Surg Case Rep       Date:  2022-07-23

8.  Clip-guided local duodenectomy for safe and minimal local resection of nonampullary duodenal neoplasms.

Authors:  Takeshi Miwa; Suguru Yamada; Kazuto Shibuya; Katsuhisa Hirano; Hideki Takami; Toru Watanabe; Masamichi Hayashi; Isaku Yoshioka; Yasuhiro Kodera; Tsutomu Fujii
Journal:  BMC Surg       Date:  2022-08-29       Impact factor: 2.030

9.  Laparoscopic segmental resection for tumours of the Angle of Treitz: a challenging but feasible surgical option. Results from a retrospective case-series analysis.

Authors:  Umberto Bracale; Emanuele Pontecorvi; Vania Silvestri; Diego Cuccurullo; Michele D'Ambra; Ruggero Lionetti; Andrea Coppola; Filippo Carannante; Felice Pirozzi; Roberto Peltrini; Antonio Sciuto; Francesco Corcione
Journal:  Updates Surg       Date:  2020-11-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.